Adhering to current clinical guidance supports evidence-based assessment, informs decision-making, and helps reduce complications in patients with bladder cancer. Ongoing review of recommendations and guidance enables clinicians to improve evaluation and management, which supports better patient outcomes.

Today's rundown features clinical guidelines and guidance regarding bladder cancer, some specifically focusing on urothelial carcinoma, the most common type of bladder cancer. Guidelines are divided into subcategories (Diagnosis/Staging, Treatment/Management, Follow-Up/Surveillance), with the first group containing guidelines that discuss bladder cancer broadly. 

Bladder Cancer Clinical Guidance
Diagnosis/Staging
Treatment/Management
Follow-Up/Surveillance 

Check out our other urology-focused content and sign up for alerts to stay informed on the latest published guidelines and insights.